Quality of bevacizumab compounded for intravitreal administration.

Palmer, J M; Amoaku, W M; Kamali, F

Palmer, J M; Amoaku, W M; Kamali, F.

Affiliation

Palmer JM; Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.

Eye (Lond) ; 27(9): 1090-7, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23788205

Subject(s)

Angiogenesis Inhibitors/chemistry; Antibodies, Monoclonal, Humanized/chemistry; Drug Packaging/standards; Bevacizumab; Drug Compounding/standards; Drug Stability; Drug Storage/methods; Immunoglobulin G/analysis; Intravitreal Injections; Particle Size; Proteins/analysis; Syringes; United Kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Drug Packaging / Antibodies, Monoclonal, Humanized Country/Region as subject: Europa Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google